Jean Buteau, Ph.D. - Publications

2004 Université de Montréal, Montréal, Canada 
Molecular Biology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Schachter D, Buteau J. Glutamate formation via the leucine-to-glutamate pathway of rat pancreas. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G938-46. PMID 24699330 DOI: 10.1152/ajpgi.00394.2013  0.6
2014 Henry C, Close AF, Buteau J. A critical role for the neural zinc factor ST18 in pancreatic β-cell apoptosis. The Journal of Biological Chemistry. 289: 8413-9. PMID 24509857 DOI: 10.1074/jbc.M114.554915  0.6
2013 Close AF, Rouillard C, Buteau J. NR4A orphan nuclear receptors in glucose homeostasis: A minireview Diabetes and Metabolism. 39: 478-484. PMID 24075454 DOI: 10.1016/j.diabet.2013.07.005  0.6
2013 Paradis R, Lazar N, Antinozzi P, Perbal B, Buteau J. Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function. Plos One. 8: e64957. PMID 23705021 DOI: 10.1371/journal.pone.0064957  0.6
2012 Talbot J, Joly E, Prentki M, Buteau J. β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells. Molecular and Cellular Endocrinology. 364: 65-70. PMID 22939843 DOI: 10.1016/j.mce.2012.08.010  0.6
2011 Bastien-Dionne PO, Valenti L, Kon N, Gu W, Buteau J. Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion. Diabetes. 60: 3217-22. PMID 22013015 DOI: 10.2337/db11-0101  0.6
2011 Buteau J. GLP-1 signaling and the regulation of pancreatic β-cells mass/function Avances En Diabetologia. 27: 3-8. DOI: 10.1016/S1134-3230(11)70002-3  0.6
2010 El-Assaad W, Joly E, Barbeau A, Sladek R, Buteau J, Maestre I, Pepin E, Zhao S, Iglesias J, Roche E, Prentki M. Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells. Endocrinology. 151: 3061-73. PMID 20444946 DOI: 10.1210/en.2009-1238  0.6
2008 Buteau J. GLP-1 receptor signaling: effects on pancreatic β-cell proliferation and survival Diabetes and Metabolism. 34. PMID 18640589 DOI: 10.1016/S1262-3636(08)73398-6  0.6
2008 Biswas SC, Buteau J, Greene LA. Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction. Neurochemical Research. 33: 1845-51. PMID 18351462 DOI: 10.1007/s11064-008-9646-4  0.6
2007 Buteau J, Accili D. Regulation of pancreatic β-cell function by the forkhead protein FoxO1 Diabetes, Obesity and Metabolism. 9: 140-146. PMID 17919188 DOI: 10.1111/j.1463-1326.2007.00782.x  0.6
2007 Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nature Medicine. 13: 1203-10. PMID 17873882 DOI: 10.1038/nm1636  0.6
2007 Buteau J, Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. The Journal of Biological Chemistry. 282: 287-93. PMID 17107961 DOI: 10.1074/jbc.M606118200  0.6
2006 Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes. 55: 1190-6. PMID 16644672 DOI: 10.2337/db05-0825  0.6
2004 Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, Buteau J, Wang X, Frankel WL, Guttridge D, Prentki M, Grey ST, Ron D, Hai T. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Molecular and Cellular Biology. 24: 5721-32. PMID 15199129 DOI: 10.1128/MCB.24.13.5721-5732.2004  0.6
2004 Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia. 47: 806-15. PMID 15095038 DOI: 10.1007/s00125-004-1379-6  0.6
2003 El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L, Prentki M. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology. 144: 4154-63. PMID 12933690 DOI: 10.1210/en.2003-0410  0.6
2003 Buteau J, Foisy S, Joly E, Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 52: 124-32. PMID 12502502 DOI: 10.2337/diabetes.52.1.124  0.6
2001 Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentki M. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes. 50: 2237-43. PMID 11574404 DOI: 10.2337/diabetes.50.10.2237  0.6
1999 Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes. 48: 2007-14. PMID 10512366 DOI: 10.2337/diabetes.48.10.2007  0.6
1999 Buteau J, Roduit R, Susini S, Prentki M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia. 42: 856-64. PMID 10440129 DOI: 10.1007/s001250051238  0.6
1993 Buteau J, Lesage AD, Kiely MC. Homicide followed by suicide: A Quebec case series, 1988-1990 Canadian Journal of Psychiatry. 38: 552-556. PMID 8242530 DOI: 10.1177/070674379303800805  0.6
Show low-probability matches.